Comparison of three different influenza vaccines in institutionalised elderly

被引:42
作者
Baldo, V
Menegon, T
Bonello, C
Floreani, A
Trivello, R
机构
[1] Univ Padua, Inst Hyg, Dept Environm Med & Publ Hlth, I-35151 Padua, Italy
[2] Mirano Local Hlth Unit 13, I-30035 Mirano, Venice, Italy
[3] Univ Padua, Dept Gastroenterol, I-35128 Padua, Italy
关键词
elderly; adjuvants; influenza vaccines;
D O I
10.1016/S0264-410X(01)00060-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The reactogenicity and the humoral immune response to three influenza vaccines were evaluated in a randomised, double-blind trial at nursing homes in north-east Italy in winter 1998-1999. Of the 285 subjects, who completed the follow-up, 93 were administered virosomal vaccine, 99 received MF59-adjuvanted vaccine and 93 had split vaccine. Ten subjects (0.3%) reported local and/or systemic reactions in the first week after immunisation. After 4 weeks, protection rates (greater than or equal to 40) were near 100% for the H1N1 and B strain and 76.0% against H3N2. The MF59-adjuvanted vaccine group had higher geometric mean titres than the other two. However, the true clinical benefit of the new adjuvanted vaccine should be further substantiated by comparative protective studies. Our results suggest that immune response to influenza vaccination in institutionalised elderly is satisfactory. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3472 / 3475
页数:4
相关论文
共 13 条
[1]   Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines - A review and meta-analysis of the literature [J].
Beyer, WEP ;
Palache, AM ;
Osterhaus, ADME .
CLINICAL DRUG INVESTIGATION, 1998, 15 (01) :1-12
[2]   Protection against influenza after annually repeated vaccination -: A meta-analysis of serologic and field studies [J].
Beyer, WEP ;
de Bruijn, IA ;
Palache, AM ;
Westendorp, RGJ ;
Osterhaus, ADME .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (02) :182-188
[3]  
*CDC, 1999, MMWR-MORBID MORTAL W, V48, P177
[4]  
Chernoff D, 1995, VACCINE DESIGN SUBUN, P277
[5]  
*COMM EUR COMM, HARM REQ INFL VACC
[6]   IMMUNITY TO INFLUENZA IN MAN [J].
COUCH, RB ;
KASEL, JA .
ANNUAL REVIEW OF MICROBIOLOGY, 1983, 37 :529-549
[7]   IMMUNOGENICITY OF NEW VIROSOME INFLUENZA VACCINE IN ELDERLY PEOPLE [J].
GLUCK, R ;
MISCHLER, R ;
FINKEL, B ;
QUE, JU ;
SCARPA, B ;
CRYZ, SJ .
LANCET, 1994, 344 (8916) :160-163
[8]   Antibody response to 1995-1996 influenza vaccine in institutionalized and non-institutionalized elderly women [J].
Iorio, AM ;
Alatri, A ;
Camilloni, B ;
Neri, M ;
Baglio, G ;
Donatelli, I .
GERONTOLOGY, 1999, 45 (01) :31-38
[9]  
MCELHANEY JE, 1994, J GERONTOL MED SCI, V49, P37
[10]   Influenza vaccines: Antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population [J].
Menegon, T ;
Baldo, V ;
Bonello, C ;
Costa, DD ;
Di Tommaso, A ;
Trivello, R .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (06) :573-576